MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spinocerebellar ataxia"

  • MDS Virtual Congress 2021

    Theory of mind in patients with cerebellar neurodegenerative disorders

    O. Tamas, A. Kacar, E. Stefanova, B. Salak Djokic, A. Milovanovic, D. Stanisavljevic, M. Kostic, N. Dragasevic Miskovic (Belgrade, Serbia)

    Objective: The aim of this study was to investigate theory of mind (ToM) in patients with different cerebellar neurodegenerative disorders (CD). Background: CD are a…
  • MDS Virtual Congress 2021

    CEREBELLAR COGNITIVE AFFECTIVE SYNDROME IN SPINOCEREBELLAR ATAXIA TYPE 3

    KH. Yap, S. Azmin, SH. Mat Desa, HN. Achok, N. Mohamed Ibrahim (Cheras, Malaysia)

    Objective: This preliminary study aims to examine whether motor and cognitive features in spinocerebellar ataxia type 3 (SCA3) are manifestations of a shared and parallel,…
  • MDS Virtual Congress 2021

    Comparative Measurement of Balance between Parkinson Disease and Spinocerebellar Ataxia – A Dynamic Posturography Study

    V. Selvaganapathy, T. James, M. Philip, N. Kamble, A. Bhattacharya, A. Stezin, P. Dhargave, P. Pal, V. Muralidharan, M. P S, P. Kishore (Bangalore, India)

    Objective: This study is conducted to compare the balance impairment between Parkinson Disease in both OFF and ON state and Spinocerebellar Ataxia. Background: The dynamic…
  • MDS Virtual Congress 2020

    Circadian rhythm alterations in an in vitro cellular model of Spinocerebellar ataxia type 17

    F. Motolese, A. Casamassa, A. Vescovi, V. Di Lazzaro, J. Rosati, M. Marano (Rome, Italy)

    Objective: To study in vitro expression of circadian rhythm genes (CLOCK, BMAL) in fibroblasts and neural cells of SCA17 patients. Background: Spinocerebellar Ataxia 17 (SCA17)…
  • MDS Virtual Congress 2020

    Clinical characterization and disease progression in spinocerebellar ataxia type 35: A case series

    C. Lin, S. Kuo (New York, NY, USA)

    Objective: To characterize the clinical presentation and disease progression of patients with spinocerebellar ataxia type 35 (SCA35). Background: Mutations in TGM6 have been identified to…
  • MDS Virtual Congress 2020

    Amantadine Therapy for Ataxia Management in Patients with Spinocerebellar Ataxia Type 7

    L. Pesantez Pacheco, N. Thakur (Houston, TX, USA)

    Objective: To report the therapeutic effects of amantadine in a patient with Spinocerebellar ataxia type 7 (SCA7) Background: Spinocerebellar ataxia type 7 is a rare…
  • MDS Virtual Congress 2020

    The use of Virtual Reality to Assess the Quality of Life in Patients with Spinocerebellar Ataxia

    B. Zeigelboim, B. Cavalcante-Leao, J.M Malisky, G.S Santos, M.S Severiani, H.T Teive (Curitiba, Brazil)

    Objective: To assess independence, confidence and balance for  development daily activities in patients with SCAs, before and after rehabilitation with virtual reality (ViR). Background: Spinocerebellar…
  • 2019 International Congress

    Sex-specific effect of ATXN2 rs7969300 polymorphism on age at onset in Spinocerebellar Ataxia type 2

    L. Almaguer-Mederos, S. Gispert, D. Almaguer-Gotay, R. Aguilera-Rodríguez, Y. González-Zaldívar, Y. Vázquez-Mojena, D. Cuello-Almarales, D. Palenzuela, G. Auburger (Havana, Cuba)

    Objective: To assess the influence of SNP rs7969300 within ATXN2 locus on the age of onset in patients with Spinocerebellar Ataxia type 2. Background: It…
  • 2019 International Congress

    Survival estimates for Spinocerebellar Ataxia type 2 based on age at onset and CAG repeats length

    L. Almaguer-Mederos, R. Aguilera-Rodríguez, Y. González-Zaldívar, D. Almaguer-Gotay, D. Cuello-Almarales, Y. Vázquez-Mojena, L. Velásquez-Pérez (Holguín, Cuba)

    Objective: To obtain survival estimates for SCA2 patients based on the age at onset and CAG repeats length . Background: Spinocerebellar ataxia type 2 (SCA2)…
  • 2019 International Congress

    Two novel ANO10 mutations causing adult-onset autosomal recessive spinocerebellar ataxia

    B. Bergmans, S. Donatello, M. Pandolfo, C. Depondt (Brugge, Belgium)

    Objective: Clinical and genetic characterization of a patient Background: In recent years mutations more than 100 different genes have been shown to underlie spinocerebellar ataxias.…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley